Key facts
- Sona (Therapeutic Devices)’s last known valuation is $3.0M (Feb 2025).
- It has raised $1.1M; the latest was Later Stage VC ($1.1M) in Feb 2025.
- Notable investors include SFC Capital, SyndicateRoom, KCP Nominees.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Sona (Therapeutic Devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for Sona (Therapeutic Devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sona (Therapeutic Devices)
Developer of a non-invasive therapeutic device designed for tinnitus treatment and stress reduction. The company's wearable earpiece integrates vagus nerve stimulation, biofeedback analysis, and personalized sound therapy, enabling individuals to regain control over their sensory experiences and improve overall well-being.
- Sector
- Healthcare
- HQ
- Tunbridge Wells, United Kingdom
- Founded
- 2018
- Employees
- 5
- Website
- sona.help/
- Ownership
- Privately Held (backing)
Sona (Therapeutic Devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sona (Therapeutic Devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sona (Therapeutic Devices) in its N-PORT filings yet. We sweep new filings monthly.